Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
Clinical trial NCT00617123 · COMPLETED
Trial details
- NCT number
- NCT00617123
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-10-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.